Finnrick - Ensuring a Safer and More Transparent Supply Chain
LSPL

LSPL
Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP antagonist) from LSPL between 11 Jun 2025 and 5 Aug 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
A
GREAT
Tentative Rating
LSPL
Tirzepatide
Tested 4 Samples
Last test 5 Aug 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from LSPL

Samples are tested in commercial labs

Tests Count

4

Scores

AVG8.0MIN6.3MAX10.0

Last

5 Aug 2025

First

11 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
5 Aug 2025View8.830mg27.900mg-7.0%99.69%May 15, 2025No Label / Silver Crimp / Pink CapLab EPublic
5 Aug 2025View10.040mg38.200mg-4.5%99.95%May 15, 2025No Label / Silver Crimp / Clear Red CapLab EPublic
3 Aug 2025View6.310mg11.190mg+11.9%99.11%202562YWWhite Label / Silver Crimp / Yellow Cap Lab APublic
11 Jun 2025View7.010mg9.220mg-7.8%99.86%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic